- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Traws Pharma Inc (TRAW)
NASDAQ
Currency in USD
Disclaimer
5.220
+0.330(+6.75%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.890
5.300
52 wk Range
4.440
27.500
TRAW Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Traws Pharma Inc stock price live, this page displays NASDAQ TRAW stock exchange data. View the TRAW premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Traws Pharma Inc real time stock price chart below.
What Is the Traws Pharma Inc Stock Price Today?
The Traws Pharma Inc stock price today is 5.220.
What Is the Stock Symbol for Traws Pharma Inc?
The stock ticker symbol for Traws Pharma Inc is TRAW.
Is TRAW the Same as $TRAW?
$TRAW is a common way to refer to the Traws Pharma Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Traws Pharma Inc Trade On?
Traws Pharma Inc is listed and trades on the NASDAQ stock exchange.
Is Traws Pharma Inc a Good Stock to Buy?
Determining whether Traws Pharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Traws Pharma Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TRAW quote. (ISIN: US68232V8845)
What Is the Traws Pharma Inc Stock Price Today?
The Traws Pharma Inc stock price today is 5.220.
What Is the Stock Symbol for Traws Pharma Inc?
The stock ticker symbol for Traws Pharma Inc is TRAW.
Is TRAW the Same as $TRAW?
$TRAW is a common way to refer to the Traws Pharma Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Traws Pharma Inc Trade On?
Traws Pharma Inc is listed and trades on the NASDAQ stock exchange.
Is Traws Pharma Inc a Good Stock to Buy?
Determining whether Traws Pharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Traws Pharma Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TRAW quote. (ISIN: US68232V8845)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.8905.300
52 wk Range
4.44027.500
UnlockTRAW Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
7.000
Upside
+34.100%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Traws Pharma Inc Company Profile
Traws Pharma, Inc., a clinical stage biopharmaceutical company, focuses on developing small molecule oral product candidates for respiratory viral diseases and cancer. The company is developing investigational novel therapies for influenza and COVID19 that are designed to address treatment resistance, such as TRX01 (travatrelvir), a Mpro/3CL inhibitor in development for the treatment of COVID19; and TRX100 (viroxavir), an endonuclease inhibitor in development for the treatment of pandemic influenza. It is also developing narazaciclib, a multi-kinase CDK4/6 inhibitor, which is in Phase 1/2 clinical trials in patients with cancer, with or without co-administration of letrozole to define the recommended phase 2 dose for further development in endometrial cancer; and oral rigosertib, which is administered alone or in combination for investigation in various cancers. The company was formerly known as Onconova Therapeutics, Inc. and changed its name to Traws Pharma, Inc. in April 2024. Traws Pharma, Inc. was incorporated in 1998 and is headquartered in Newtown, Pennsylvania.
Compare TRAW to Peers and Sector
Metrics to compare | TRAW | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTRAWPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.1x | −2.0x | −0.6x | |
PEG Ratio | 0.00 | 0.04 | 0.00 | |
Price / Book | −0.1x | 0.8x | 2.6x | |
Price / LTM Sales | 42.2x | 1.9x | 3.2x | |
Upside (Analyst Target) | 34.1% | 59.1% | 44.2% | |
Fair Value Upside | Unlock | 13.1% | 7.9% | Unlock |
People Also Watch
FAQ
What Is the Traws Pharma (TRAW) Stock Price Today?
The Traws Pharma stock price today is 5.22
What Stock Exchange Does Traws Pharma Trade On?
Traws Pharma is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Traws Pharma?
The stock symbol for Traws Pharma is "TRAW."
What Is the Traws Pharma Market Cap?
As of today, Traws Pharma market cap is 9.53M.
What is Traws Pharma Earnings Per Share?
The Traws Pharma EPS is -155.09.
What Is the Next Traws Pharma Earnings Date?
Traws Pharma will release its next earnings report on Nov 13, 2024.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.